Post by Akshit Kumar

💡The clinical evidence for vision therapy is overwhelming… so why are most optometrists still not offering it? 💡 This is one of those uncomfortable questions the eye care industry tends to avoid. ✍ Because on paper, the evidence does exist. Multiple studies support vision therapy for conditions like: ✅ Convergence insufficiency ✅ Accommodative dysfunction ✅ Certain binocular vision disorders And yet in real-world clinical practice, it remains surprisingly underutilized. So what’s actually going on? 🤔 It’s not a simple “evidence vs. no evidence” debate. It’s something deeper. 1. Training gap, not just knowledge gap ➡️ Most optometrists are trained to prescribe lenses and detect pathology — not to rehabilitate visual function. 2. System bias ➡️ Eye care systems are built around correction, not training. Glasses = scalable. Therapy = time-intensive. 3. The skepticism loop ➡️ Limited exposure → low adoption → fewer clinicians practicing it → slower mainstream validation. And meanwhile, something is changing quietly in the background: 📱 Screen-heavy lifestyles 🧠 Rising visual stress in children and adults 👁️ Increasing awareness of binocular vision problems Which leads to a bigger question: ❓ Are we under-treating functional vision problems simply because our system wasn’t designed for them? ❓ Or are we right to stay cautious until stronger standardization emerges? Either way, ignoring the conversation is no longer an option. Because patients don’t care about silos. They care about results. And the gap between “what is known in research” and “what is done in clinics” might be one of the biggest untapped opportunities in modern eye care. Curious to hear from optometrists, ophthalmologists, and founders here: 👉 Is vision therapy underutilized because of evidence, education, or economics? #VisionTherapy #Optometry #EyeCare #BinocularVision #HealthcareInnovation #MedTech #DigitalHealth #NeuroVision #HealthcareStartups #Orbsway